Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

On Crowncast, Enrico Pesenti explains how cancer drug resistance forms and how advanced technologies are helping researchers ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A new set of genes that contribute to Parkinson’s disease risk has been identified.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

The Asia Pacific region is poised for a significant surge in the CRISPR gene editing market, projected to expand by 28.6% annually over the period of 2022-2031. With a total addressable market cap ...

To address this question, a new study from Northwestern Medicine used modern technology, called CRISPR interference ...